Multiple Assemblies exist for SMTL entry 8bdn
VCB in complex with compound 23; X-RAY DIFFRACTION 2.76 Å

	SMTL ID 8bdn.1 Ligands (2~{R})-3-methyl-1-[(2~{S},4~{R})-2-[(5~{R})-5-methyl-5-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]-4~{H}-1,2,4-oxadiazol-3-yl]-4-oxidanyl-pyrrolidin-1-yl]-2-(3-methyl-1,2-oxazol-5-yl)butan-1-one Polypeptides Elongin-B; Elongin-C; von Hippel-Lindau disease tumor suppressor Oligo-state hetero-2-1-1-mer
	SMTL ID 8bdn.2 Ligands (2~{R})-3-methyl-1-[(2~{S},4~{R})-2-[(5~{R})-5-methyl-5-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]-4~{H}-1,2,4-oxadiazol-3-yl]-4-oxidanyl-pyrrolidin-1-yl]-2-(3-methyl-1,2-oxazol-5-yl)butan-1-one Polypeptides von Hippel-Lindau disease tumor suppressor; Elongin-B; Elongin-C Oligo-state hetero-1-1-2-mer
	SMTL ID 8bdn.3 Ligands (2~{R})-3-methyl-1-[(2~{S},4~{R})-2-[(5~{R})-5-methyl-5-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]-4~{H}-1,2,4-oxadiazol-3-yl]-4-oxidanyl-pyrrolidin-1-yl]-2-(3-methyl-1,2-oxazol-5-yl)butan-1-one Polypeptides von Hippel-Lindau disease tumor suppressor; Elongin-B Oligo-state hetero-2-1-mer
	SMTL ID 8bdn.4 Ligands (2~{R})-3-methyl-1-[(2~{S},4~{R})-2-[(5~{R})-5-methyl-5-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]-4~{H}-1,2,4-oxadiazol-3-yl]-4-oxidanyl-pyrrolidin-1-yl]-2-(3-methyl-1,2-oxazol-5-yl)butan-1-one Polypeptides Elongin-C; von Hippel-Lindau disease tumor suppressor Oligo-state hetero-1-2-mer